DEA schedule
Is hydrocodone a controlled substance?
Federal schedule for hydrocodone from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Hydrocodone is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Hydrocodone (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted hydrocodone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 19 prescription listings from 2 labelers, all Schedule II |
| DEA controlled substances list | Hydrocodone: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Hydrocodone | 9193 | II | Yes | Dihydrocodeinone | Listed by name |
Hydrocodone NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 59011-276 | Hysingla ER | tablet, extended release | 100 mg/1 | Knoa Pharma LLC | CII |
| 59011-271 | Hysingla ER | tablet, extended release | 20 mg/1 | Knoa Pharma LLC | CII |
| 59011-272 | Hysingla ER | tablet, extended release | 30 mg/1 | Knoa Pharma LLC | CII |
| 59011-273 | Hysingla ER | tablet, extended release | 40 mg/1 | Knoa Pharma LLC | CII |
| 59011-274 | Hysingla ER | tablet, extended release | 60 mg/1 | Knoa Pharma LLC | CII |
| 59011-275 | Hysingla ER | tablet, extended release | 80 mg/1 | Knoa Pharma LLC | CII |
| 47781-409 | Hydrocodone Bitartrate | capsule, extended release | 10 mg/1 | Alvogen Inc. | CII |
| 47781-410 | Hydrocodone Bitartrate | capsule, extended release | 15 mg/1 | Alvogen Inc. | CII |
| 47781-411 | Hydrocodone Bitartrate | capsule, extended release | 20 mg/1 | Alvogen Inc. | CII |
| 47781-412 | Hydrocodone Bitartrate | capsule, extended release | 30 mg/1 | Alvogen Inc. | CII |
| 47781-413 | Hydrocodone Bitartrate | capsule, extended release | 40 mg/1 | Alvogen Inc. | CII |
| 47781-414 | Hydrocodone Bitartrate | capsule, extended release | 50 mg/1 | Alvogen Inc. | CII |
| 47781-397 | Hydrocodone Bitartrate | tablet, extended release | 100 mg/1 | Alvogen Inc. | CII |
| 47781-398 | Hydrocodone Bitartrate | tablet, extended release | 120 mg/1 | Alvogen Inc. | CII |
| 47781-392 | Hydrocodone Bitartrate | tablet, extended release | 20 mg/1 | Alvogen Inc. | CII |
| 47781-393 | Hydrocodone Bitartrate | tablet, extended release | 30 mg/1 | Alvogen Inc. | CII |
| 47781-394 | Hydrocodone Bitartrate | tablet, extended release | 40 mg/1 | Alvogen Inc. | CII |
| 47781-395 | Hydrocodone Bitartrate | tablet, extended release | 60 mg/1 | Alvogen Inc. | CII |
| 47781-396 | Hydrocodone Bitartrate | tablet, extended release | 80 mg/1 | Alvogen Inc. | CII |
Questions
Is hydrocodone a controlled substance?
Yes. Hydrocodone is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Hydrocodone (Schedule II).
Is hydrocodone a narcotic?
Yes. The DEA list marks hydrocodone as a narcotic (NARC = Y) and places it in Schedule II. Its FDA established pharmacologic class is Opioid Agonist.
What schedule is hydrocodone?
Hydrocodone is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Hydrocodone
- What is Hydrocodone used for?FDA label uses
- Generic for Zohydro ERFDA Orange Book
- Generic for Hysingla ERFDA Orange Book
- Generic for Vantrela ERFDA Orange Book
- What is Hysingla ER used for?FDA label uses
- Is Hysingla ER a controlled substance?Schedule II
- Opioid Agonists listFDA drug class
- NDC 59011-271Hydrocodone NDC record
- NDC 59011-272Hydrocodone NDC record
- NDC 59011-273Hydrocodone NDC record
- Schedule II drugs listDEA schedule